Total Payments
$15,136
2024 Payments
$3,702
Companies
39
Transactions
647
Medicare Patients
3,903
Medicare Billing
$2.2M
Payment Breakdown by Category
Food & Beverage$13,595 (89.8%)
Consulting$1,386 (9.2%)
Education$130.91 (0.9%)
Travel$24.20 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,595 | 639 | 89.8% |
| Consulting Fee | $1,386 | 4 | 9.2% |
| Education | $130.91 | 3 | 0.9% |
| Travel and Lodging | $24.20 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,208 | 151 | $0 (2024) |
| GENZYME CORPORATION | $1,771 | 14 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,383 | 73 | $0 (2024) |
| CSL Behring | $806.96 | 42 | $0 (2024) |
| Octapharma USA, Inc. | $742.07 | 22 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $674.25 | 30 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $617.93 | 26 | $0 (2024) |
| PFIZER INC. | $611.69 | 34 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $545.56 | 24 | $0 (2024) |
| Shire North American Group Inc | $521.10 | 28 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,702 | 86 | GENZYME CORPORATION ($1,572) |
| 2023 | $2,585 | 124 | AstraZeneca Pharmaceuticals LP ($433.37) |
| 2022 | $1,795 | 89 | AstraZeneca Pharmaceuticals LP ($411.01) |
| 2021 | $1,348 | 68 | AstraZeneca Pharmaceuticals LP ($295.23) |
| 2020 | $1,103 | 57 | AstraZeneca Pharmaceuticals LP ($300.26) |
| 2019 | $1,821 | 75 | AstraZeneca Pharmaceuticals LP ($514.80) |
| 2018 | $1,722 | 95 | AstraZeneca Pharmaceuticals LP ($470.23) |
| 2017 | $1,060 | 53 | AstraZeneca Pharmaceuticals LP ($186.24) |
All Payment Transactions
647 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Inflammation | ||||||
| 12/17/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $29.50 | General |
| Category: Immunology | ||||||
| 12/13/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Respiratory | ||||||
| 12/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Immunology | ||||||
| 12/03/2024 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $1,320.00 | General |
| 12/03/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $113.77 | General |
| 12/03/2024 | GENZYME CORPORATION | — | Travel and Lodging | Cash or cash equivalent | $24.20 | General |
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Inflammation | ||||||
| 11/12/2024 | ADMA BioManufacturing LLC | — | Consulting Fee | Cash or cash equivalent | $23.08 | General |
| 11/11/2024 | Octapharma USA, Inc. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/07/2024 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: Immunology | ||||||
| 11/05/2024 | ALK-Abello, Inc | Odactra (Drug), Grastek, Ragwitek | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Allergy and Immunology | ||||||
| 11/04/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $29.16 | General |
| Category: BIOLOGIC | ||||||
| 10/30/2024 | Octapharma USA, Inc. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $25.03 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: BIOLOGIC | ||||||
| 10/14/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Inflammation | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $26.89 | General |
| Category: Immunology | ||||||
| 09/23/2024 | Octapharma USA, Inc. | CUTAQUIG (Biological) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: IMMUNOLOGY | ||||||
| 09/20/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: BIOLOGIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 1,073 | 15,681 | $1.7M | $560,158 |
| 2022 | 31 | 1,116 | 16,156 | $1.7M | $568,467 |
| 2021 | 27 | 929 | 15,735 | $1.6M | $496,632 |
| 2020 | 23 | 785 | 17,626 | $1.8M | $535,734 |
Total Patients
3,903
Total Services
65,198
Medicare Billing
$2.2M
Procedure Codes
110
All Medicare Procedures & Services
110 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1556 | Injection, immune globulin (bivigam), 500 mg | Office | 2023 | 17 | 4,040 | $606,000 | $227,404 | 37.5% |
| J2357 | Injection, omalizumab, 5 mg | Office | 2023 | 15 | 6,570 | $624,150 | $198,760 | 31.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 130 | 272 | $68,000 | $20,689 | 30.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 91 | 184 | $64,400 | $19,610 | 30.5% |
| 88185 | Flow cytometry technique for dna or cell analysis, each additional marker | Office | 2023 | 22 | 748 | $56,100 | $17,435 | 31.1% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 28 | 857 | $40,930 | $12,155 | 29.7% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 25 | 167 | $41,249 | $11,469 | 27.8% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 24 | 95 | $21,755 | $5,873 | 27.0% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 24 | 291 | $43,650 | $5,606 | 12.8% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 101 | 154 | $15,400 | $5,434 | 35.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 42 | 103 | $17,716 | $5,079 | 28.7% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 22 | 25 | $7,500 | $3,495 | 46.6% |
| 95018 | Test for allergy using combination of methods with drug or biological | Office | 2023 | 12 | 166 | $11,288 | $3,171 | 28.1% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 34 | 852 | $19,596 | $3,122 | 15.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 32 | 32 | $8,000 | $2,908 | 36.3% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 73 | 247 | $11,115 | $2,646 | 23.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $4,200 | $1,884 | 44.9% |
| 95180 | Injection for rapid desensitization to allergen | Office | 2023 | 12 | 14 | $4,200 | $1,751 | 41.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 129 | $6,450 | $1,630 | 25.3% |
| 88184 | Flow cytometry technique for dna or cell analysis, first marker | Office | 2023 | 22 | 22 | $3,300 | $1,603 | 48.6% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 55 | 69 | $6,900 | $1,571 | 22.8% |
| 88189 | Flow cytometry technique for dna or cell analysis, 16 or more markers | Office | 2023 | 22 | 22 | $5,500 | $1,534 | 27.9% |
| 96361 | Infusion into a vein for hydration, each additional hour | Office | 2023 | 23 | 93 | $9,300 | $1,125 | 12.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 15 | 15 | $1,125 | $1,079 | 95.9% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 132 | 399 | $19,950 | $978.36 | 4.9% |
About Dr. Carla Ward, MD
Dr. Carla Ward, MD is a Allergy & Immunology healthcare provider based in Chevy Chase, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275557274.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carla Ward, MD has received a total of $15,136 in payments from pharmaceutical and medical device companies, with $3,702 received in 2024. These payments were reported across 647 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($13,595).
As a Medicare-enrolled provider, Ward has provided services to 3,903 Medicare beneficiaries, totaling 65,198 services with total Medicare billing of $2.2M. Data is available for 4 years (2020–2023), covering 110 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Location Chevy Chase, MD
- Active Since 07/26/2006
- Last Updated 04/27/2015
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1275557274
Products in Payments
- TEZSPIRE (Biological) $976.01
- CUVITRU (Biological) $947.85
- NUCALA (Biological) $899.04
- DUPIXENT (Biological) $776.66
- SYMBICORT (Drug) $730.24
- FASENRA (Drug) $628.55
- Hizentra (Biological) $552.51
- CUTAQUIG (Biological) $493.92
- Xolair (Biological) $458.85
- FASENRA (Biological) $446.13
- Xhance (Drug) $413.57
- ORLADEYO (Drug) $394.99
- AUVI-Q (Drug) $372.20
- XOLAIR (Drug) $367.96
- RUCONEST (Biological) $358.56
- XOLAIR (Biological) $306.29
- EUCRISA (Drug) $277.33
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) $263.58
- Haegarda (Biological) $254.45
- TRELEGY ELLIPTA (Drug) $237.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.